Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Nanosonics Limited ( (AU:NAN) ) just unveiled an update.
UBS Group AG and its related bodies corporate have ceased to be substantial shareholders in Nanosonics Limited as of 7 May 2026, according to a regulatory notice filed under Australian Corporations Law. The change reflects a reduction in UBS’s voting interest below the substantial holding threshold, signaling a shift in the company’s institutional investor base that may alter the balance of major shareholders without directly affecting day-to-day operations.
While specific transaction details are contained in an appendix, the notice confirms that no new associates or changes in association are involved in UBS’s exit as a substantial holder. The development may be watched by investors as an indicator of evolving sentiment among large financial institutions toward Nanosonics’ stock, potentially influencing market perceptions of the company’s capital structure and liquidity.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.55 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited is a medical technology company focused on infection prevention solutions for healthcare settings. The company is known for its disinfection systems used in hospitals and clinics, targeting improved safety and compliance in the handling of medical instruments and devices.
YTD Price Performance: -14.36%
Average Trading Volume: 811,195
Technical Sentiment Signal: Sell
Current Market Cap: A$1.02B
Learn more about NAN stock on TipRanks’ Stock Analysis page.